It describes some patients plateauing at a lower step with good weight loss and minimal nausea, while others need the upper end of the range to reach clinical goals
All participants had a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity
However, the SURPASS J-mono trial found that although HbA1c reductions increased with higher tirzepatide doses, differences in weight loss between 10 and 15 mg were modest, which is consistent with our observations [6]
Testing scope Whether third-party testing applies to the entire blended product , rather than only to individual peptide components
When patients eventually stop taking them (and most will at some point), the habits youve helped them build will determine whether they maintain their weight loss or regain
We provide our patients with the NeoClear by Aerolase acne treatment, the NeoSkin by Aerolase melasma and hyperpigmentation treatment, and a host of other skin conditions